Independent provider comparison
Updated September 27, 2026
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
This page compares Embody with Hims. Looking for Hers? Compare Embody vs Hers →
The short decision
Start with Embody if a clinician finds a compounded injection appropriate and your priority is the lower published cash-pay entry. Start with Hims if you want an FDA-approved brand-name pill or pen and accept a separate required membership. Embody lists one-month compounded semaglutide at $79. Hims lists medication from $149, but its required membership brings the lowest path to $188 in month one and at least $298 monthly after that. These are different products and different billing structures, so the lowest headline alone should not decide.
Embody pays us a commission through our links. Hims does not currently pay us for this comparison. That difference does not set scores or change the documented fit of either option. How we make money.
Our pick for a lower-cost cash-pay injection entry
Embody publishes a $79 one-month compounded semaglutide plan with medication, clinical review and shipping included. It also offers compounded tirzepatide injections.
Treatment requires clinical approval. The medication is compounded and is not FDA approved. Longer plans lower the monthly equivalent but require more money up front.
Choose Hims for brand-name pills and pens
Hims lists FDA-approved brand-name oral and injectable options, including Wegovy pill and pen, through a familiar telehealth platform with ongoing app-based care.
Medication is billed separately from a required Weight Loss Membership. The lowest listed medication path totals $188 in month one and at least $298 monthly after that before product or dose increases.
Sources: Embody product catalogue · Hims medications, membership and pricing · FDA questions and answers on compounded drugs
Side by side
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Embody | Hims |
|---|---|---|
Why each oneEmbodyPublishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied. HimsThe only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 2.9 Trustpilot rating that lags peers. | ||
| Last Published Score | 7.3/10 | 5.9/10 |
| Headline Price | from $69/mo | $188 first month, then $298/mo |
| Medication Type | Compounded | Brand |
| Insurance Accepted | No | No |
Best ForEmbodyPeople who want to compare Embody's published plan menu with its separate monthly promotion and will confirm the exact charge, term and refund rules before paying HimsMen who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | ||
Watch out forEmbodyPayments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date. HimsPending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. | ||
| Get started | Visit Embody | View Hims terms |
Compare the full bill, not just the advertised monthly number. These are published terms, not a personal prescription quote. We may earn a commission from marked partner links; other providers appear here for comparison. Scores use our last published assessment; source dates below distinguish price checks from that assessment. How our links work.
The $69 headline is not a flat verified checkout price. The public catalogue lists $79/$129 for one month and $69/$119 monthly equivalents on twelve-month prepay ($828/$1,428). A separate promotion advertises $69/$119 flat monthly, while the still-published April 24 terms list different introductory and fixed-price programs. Which terms apply to the final offer and renewal remains unverified. Sources checked September 27, 2026.
Compounded Semaglutide Injection (advertised plan floor): $79. Month-to-month rate. Public catalogue ladder checked 2026-09-20: $79 monthly, $76/mo on 3 months ($228), $73/mo on 6 ($438), $69/mo on 12 ($828). This row is the catalogue plan, not the separate offer described in the review.
Compounded Tirzepatide (GLP-1 + GIP) Injection (advertised plan floor): $129. Month-to-month rate. Public catalogue ladder checked 2026-09-20: $129 monthly, $126/mo on 3 months ($378), $123/mo on 6 ($738), $119/mo on 12 ($1,428). This row is the catalogue plan, not the separate offer described in the review.
Cancellation: Choose a 4-, 12-, 24- or 52-week plan at signup. Cancellation requests must reach support at least 72 hours before the next billing date, and the policy dated August 25, 2026 says all payments are final and non-refundable, with a refund for unused services on provider-determined medical disqualification, after deductions for services already provided. Multi-month plans are non-refundable in whole and in part. Refill orders triggered by user-completed optional refill intake can pull the next billing date forward.
Price source checked September 20, 2026. Confirm current eligibility, medication, term and total before paying.
Embody official pricing sourceall-in floor for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies
All-in $149-medication path (first month): $188. $149 medication + required $39 first-month Weight Loss Membership; exact product and dose price varies
All-in $149-medication path (ongoing): $298. $149 medication + required $149/mo ongoing Weight Loss Membership; exact product and dose price varies
Weight Loss Membership (first month): $39. Required first-month membership; medication is billed separately
Weight Loss Membership (ongoing): $149. Required monthly membership after month one; medication is billed separately
Wegovy Pill (medication only): $149. FDA-approved oral Wegovy medication from $149; required membership is billed separately and exact dose price varies
Wegovy Pen (medication only): $199. FDA-approved Wegovy pen medication from $199; required membership is billed separately and exact dose price varies
Foundayo Pill (medication only): $149. FDA-approved Foundayo medication from $149; required membership is billed separately and exact dose price varies
Ozempic Pill (medication only): $149. FDA-approved Ozempic pill medication from $149; required membership is billed separately and exact dose price varies
Ozempic Pen (medication only): $199. FDA-approved Ozempic pen medication from $199; required membership is billed separately and exact dose price varies
Zepbound Vial or KwikPen (medication only): $299. FDA-approved Zepbound medication from $299; required membership is billed separately and exact product or dose price varies
Mounjaro or Zepbound (retail cash): $1899. Both are listed at a flat $1,899/mo on the weight loss page, against $299/mo for the Zepbound vial and KwikPen; required membership is billed separately. Most eligible users will compare lower manufacturer-direct or discounted paths.
Wegovy Pill Microdosing Plan (medication only): $149. Daily Wegovy pill at a 1.5 mg starting dose, from $149 on the weight loss page; required membership is billed separately and exact dose price varies
Cancellation: Cancel in the app, in your online account under My Subscriptions, by email to the Customer Help Center, or by phone. The terms require cancelling at least two days before the next billing date, the first month membership fee is non-refundable, and medication is not refundable once it has shipped (verified 2026-09-03)
Price source checked September 3, 2026. Confirm current eligibility, medication, term and total before paying.
Hims official pricing sourceScore evidence last assessed September 3, 2026.
Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. FDA's explanation of compounded-drug risks.
Trade-offs
2 more documented strengths
3 more documented cautions
2 more documented strengths
6 more documented cautions
Embody's catalogue lists one month of compounded semaglutide at $79 and one month of compounded tirzepatide at $129. Medication, clinical review and shipping are included. Its lowest monthly equivalents require prepayment: twelve months cost $828 for semaglutide, equal to $69 per month, or $1,428 for tirzepatide, equal to $119 per month. A separate promotional landing advertises $69 and $119 as monthly offers, but we have not independently verified the final promotional checkout charge or term. Compare the total due today, not only the monthly-looking number.
Hims lists several medications from $149, including Wegovy pill, Foundayo and Ozempic pill. Its Weight Loss Membership is required and billed separately at $39 for month one, then $149 monthly. That makes a $149 medication path $188 initially and at least $298 in a later month if the same medication price applies. Wegovy and Ozempic pens start at $199 and Zepbound starts at $299 before membership, so the exact product and dose can raise the total.
Sources: Embody catalogue · Embody plan-by-plan pricing · Hims weight-loss prices
Embody's current catalogue focuses on compounded semaglutide and compounded tirzepatide injections. It does not currently list brand-name Wegovy, Zepbound, Ozempic or Mounjaro, and its former oral tirzepatide gum is no longer in the catalogue. Embody names four 503A pharmacy partners but does not say which pharmacy will fill a specific prescription before approval.
Hims' retail menu is built around brand-name options. It lists Wegovy as a daily pill and weekly pen, Foundayo as a pill, Ozempic as a pill and pen, Zepbound, and Mounjaro. Ozempic and Mounjaro are FDA approved for diabetes rather than weight loss, so any weight-loss use is an off-label clinical decision. Availability and eligibility still depend on the prescriber, product supply and the shopper's state.
The practical split is clear: Embody is the narrower compounded-injection route, while Hims offers more brand-name forms. Compounded products are not FDA approved and are not generic versions of approved brands. FDA does not review compounded drugs for safety, effectiveness or quality before marketing.
Sources: Embody current products · Hims current medication menu · FDA on compounded drugs
Hims is the relevant choice between these two if you want to discuss a pill. Its current menu includes brand-name oral options. Embody's current catalogue lists injections, so it is not the better fit for a needle-free shopper.
Do not choose a pill only because it avoids a needle. Ask which product and dose you may qualify for, whether the medicine is approved for your intended use, what the complete recurring bill is, and how dosing or side effects may differ. Our Wegovy pill guide owns the broader oral-medication question and tracks the current options separately.
Sources: Hims oral and injectable options · Current Wegovy pill guide
Embody says its plan includes an online assessment, clinician review through OpenLoop Health, coaching and shipping. A clinician decides whether treatment is appropriate after checkout. The individual clinician and dispensing pharmacy are not named before signup.
Hims separates care from medication on the bill. Its required membership includes access to a care team, in-app messaging and tracking, dosage adjustments when clinically appropriate, and other support described on its weight-loss page. A membership payment does not guarantee a prescription, and medication remains a separate charge.
Choose the care model you will actually use. A lower bundled price has more value if you are comfortable with Embody's narrower injection program. Hims' higher continuing bill may be worth considering if its brand-name menu, pill access and established app experience solve a need Embody does not.
Sources: Embody program and included care · Hims membership and care features · Independent Embody review
For Embody, confirm the exact medication, total charged today, plan length, refill timing and which pharmacy will fill the prescription. Payments are normally non-refundable. Embody's policy provides a limited refund for unused services when its provider determines medical disqualification, after deducting services already provided. Other cancellations stop future renewal and must reach support at least 72 hours before the next billing date.
For Hims, confirm the membership charge and medication charge as separate lines, the product and dose, state availability, shipping if any, and the next billing date. Hims says the first membership fee is non-refundable and asks customers to cancel at least two days before renewal. Medication is not refundable once shipped.
For either service, save the checkout terms and confirmation. If you are changing providers, do not cancel an existing prescription path until the receiving clinician has reviewed your treatment and you understand the next refill plan.
Sources: Embody refund and cancellation policy · Hims program and billing information
No. Embody's current catalogue lists compounded semaglutide and tirzepatide injections. Hims lists the brand-name Wegovy pill. Eligibility, dose and final price require clinical review.
Not on the lowest published complete cash-pay examples. Embody lists one-month compounded semaglutide at $79 with care and shipping included. Hims' lowest listed $149 medication plus its required $39 first-month membership totals $188 initially, then at least $298 monthly when the membership becomes $149. The products are not equivalent, so choose by treatment need as well as total price.
Both comparison records are cash-pay paths and neither bills insurance for the programs described here. Hims says some medication expenses may be FSA or HSA eligible, while its membership is not. Confirm eligibility with your plan or account administrator before relying on reimbursement.
Keep narrowing the decision
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit, with the verification evidence behind each answer.
